Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,992 | 34,438 | 9,627 | 21,399 | 23,310 |
| Depreciation Amortization | 2,883 | 2,472 | 1,483 | 762 | 816 |
| Income taxes - deferred | 11,028 | -15,211 | N/A | N/A | N/A |
| Accounts receivable | -13,565 | -916 | 241 | -788 | -251 |
| Accounts payable and accrued liabilities | -543 | 399 | 115 | 763 | 58 |
| Other Working Capital | -16,830 | -2,258 | 741 | 93 | -2,400 |
| Other Operating Activity | 14,708 | 1,255 | -1,554 | 394 | 2,486 |
| Operating Cash Flow | $76,673 | $20,179 | $10,653 | $22,623 | $24,019 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,336 | -1,028 | -606 | -186 | -436 |
| Purchase Of Investment | -196,304 | -98,405 | -115,888 | -47,694 | -33,574 |
| Sale Of Investment | 110,617 | 99,927 | 47,278 | 28,700 | 16,764 |
| Other Investing Activity | -163 | 3 | 0 | 1,140 | -436 |
| Investing Cash Flow | $-88,186 | $497 | $-69,216 | $-18,040 | $-17,682 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,000 |
| Debt Repayment | 0 | 0 | N/A | N/A | -2,000 |
| Common Stock Issued | 726 | 1,054 | 60,451 | -909 | 34 |
| Common Stock Repurchased | N/A | N/A | -3,540 | N/A | N/A |
| Other Financing Activity | 1,814 | 110 | 0 | 0 | 0 |
| Financing Cash Flow | $2,540 | $1,164 | $56,911 | $-909 | $34 |
| Beginning Cash Position | 30,699 | 8,859 | 10,511 | 6,837 | 466 |
| End Cash Position | 21,726 | 30,699 | 8,859 | 10,511 | 6,837 |
| Net Cash Flow | $-8,973 | $21,840 | $-1,652 | $3,674 | $6,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | 76,673 | 20,179 | 10,653 | 22,623 | 24,019 |
| Capital Expenditure | -2,336 | -1,028 | -606 | -252 | -445 |
| Free Cash Flow | 74,337 | 19,151 | 10,047 | 22,371 | 23,574 |